Verona Adds Two Board Members
This article was originally published in Scrip
Executive Summary
Verona Pharma plc, a drug development company focused on respiratory diseases, has appointed Ken Cunningham and Dr. Anders Ullman to its board of directors as non-executive directors – effective Sep. 10, 2015.